"Bridging" therapy in patients on long-term vitamin K antagonist treatment: a yet unsolved issue.
Baudo
Francesco
F
Haemostasis and Thrombosis Unit, Niguarda Ca' Granda Hospital, Milan, Italy. md9821@mclink.it
D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications; D015331:Cohort Studies; D006470:Hemorrhage / Q000517:prevention & control*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007430:Intraoperative Care; D018570:Risk Assessment; D012307:Risk Factors; D013514:Surgical Procedures, Operative; D013923:Thromboembolism / Q000517:prevention & control*; D013997:Time Factors; D014812:Vitamin K / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014812:Vitamin K